CARBAMAZEPINE METABOLISM IN MAN INDUCTION AND PHARMACOGENETIC ASPECTS

被引:185
作者
EICHELBAUM, M
TOMSON, T
TYBRING, G
BERTILSSON, L
机构
[1] KAROLINSKA INST, HUDDINGE UNIV HOSP, DEPT CLIN PHARMACOL, S-14186 HUDDINGE, SWEDEN
[2] UNIV BONN, DEPT MED, D-5300 BONN, GERMANY
[3] SODER HOSP, DEPT NEUROL, STOCKHOLM, SWEDEN
关键词
D O I
10.2165/00003088-198510010-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolism of carbamazepine (CBZ) was studied in 3 groups of subjects: 6 healthy volunteers given a single dose of 200 mg carbamazepine; 4 epileptic patients on carbamazepine monotherapy; and 5 patients receiving carbamazepine in combination with other anticonvulsants. Carbamazepine kinetics in the patients were investigated by use of 15N-CBZ. The mean plasma clearance of carbamazepine were 19.8, 54.6 and 113.3 ml/h per kg in groups 1, 2, and 3, respectively. The increased clearance in the patients was mainly due to an induction of the epoxide-diol pathway, as reflected by an increased urinary excretion of the trans-CBZ-diol metabolite. The urinary excretion (as a percentage of the administered dose) of 9-hydroxymethyl-10-carboamoylacridan (9-OH-CBZ) was also increased, whereas the excretion of 2-OH-CBZ and 3-OH-CBZ [2-hydroxycarbamazepine and 3-hydroxycarbamazepine] in groups 2 and 3 were decreased in comparison with group 1. 9-OH-CBZ is formed from carbamazepine-10,11-epoxide (CBZ-E) or trans-CBZ-diol, the formation of 9-OH-CBZ was investigated in 3 patients with trigeminal neuralgia treated with carbamazepine or CBZ-E as monotherapy on separate occasions. The urinary excretion of 9-OH-CBZ was 1.9, 3.3 and 4.0% of the trans-CBZ-diol excretion during CBZ-E therapy and 23, 32 and 24%, respectively, during carbamazepine therapy is formed via the epoxide-diol pathway. Data on plasma concentrations of carbamazepine and CBZ-E, and on urinary excretion of trans-CBZ-diol from 4 patients on carbamazepine therapy were used to calculate the plasma clearance of CBZ-E. The hydration of CBZ-E during carbamazepine therapy was found to be induced, but to a lesser extent than the expoxidation and oxidative metabolic reactions of some other drugs was also studied in 8 healthy volunteers. Carbamazepine epoxidation was not correlated to 4-hydroxylation debrisoquine, oxidation of sparteine, 3- and 4-hydroxylation demethylation of antipyrine, demethylation of amitriptyline, or total metabolism of theophylline.
引用
收藏
页码:80 / 90
页数:11
相关论文
共 34 条
[1]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[2]   PREDICTION OF STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE FROM SINGLE ORAL DOSE KINETICS - STUDY IN TWINS [J].
ALEXANDERSON, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) :44-53
[3]  
[Anonymous], 2010, CLIN PHARMACOKINET
[4]  
[Anonymous], 1975, Clinical Pharmacology of Anti-Epileptic Drugs
[5]   AUTO-INDUCTION OF CARBAMAZEPINE METABOLISM IN CHILDREN EXAMINED BY A STABLE ISOTOPE TECHNIQUE [J].
BERTILSSON, L ;
HOJER, B ;
TYBRING, G ;
OSTERLOH, J ;
RANE, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) :83-88
[6]   FAMILY STUDY OF ANTIPYRINE CLEARANCE [J].
BLAIN, PG ;
MUCKLOW, JC ;
WOOD, P ;
ROBERTS, DF ;
RAWLINS, MD .
BRITISH MEDICAL JOURNAL, 1982, 284 (6310) :150-152
[8]  
CHRISTIANSEN J, 1973, ACTA NEUROL SCAND, V49, P543
[9]   THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM [J].
DAHLQVIST, R ;
BERTILSSON, L ;
BIRKETT, DJ ;
EICHELBAUM, M ;
SAWE, J ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :815-821
[10]  
DAM M, 1980, ANTIEPILEPTIC THERAP, P299